{"id":66508,"date":"2026-04-02T11:57:40","date_gmt":"2026-04-02T06:27:40","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=66508"},"modified":"2026-04-02T11:57:42","modified_gmt":"2026-04-02T06:27:42","slug":"sai-parenteral-ipo-listing-at-2-04-premium-at-400-00-per-share","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sai-parenteral-ipo-listing-at-2-04-premium-at-400-00-per-share\/","title":{"rendered":"Sai Parenteral IPO Listing at 2.04% Premium at \u20b9400.00 Per Share\u00a0"},"content":{"rendered":"<p><strong>Sai Parenteral IPO Listing Today: <\/strong>The Sai Parenteral IPO was subscribed 2.05 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 14.98 times, and non-institutional investors (NIIs) received 1.16 times. The retail quota of the issue was subscribed to 56.03%. Before delving deeper into the topic, go through the details of the Sai Parenteral IPO.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/sai-parenteral-ipo-listing-at-2-04-premium-at-400-00-per-share\/#Sai_Parenteral_IPO\" title=\"Sai Parenteral IPO\">Sai Parenteral IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/sai-parenteral-ipo-listing-at-2-04-premium-at-400-00-per-share\/#Sai_Parenteral_Listing\" title=\"Sai Parenteral Listing\">Sai Parenteral Listing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/sai-parenteral-ipo-listing-at-2-04-premium-at-400-00-per-share\/#About_Sai_Parenteral_Limited\" title=\"About Sai Parenteral Limited\">About Sai Parenteral Limited<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/sai-parenteral-ipo-listing-at-2-04-premium-at-400-00-per-share\/#Sai_Parenterals_Limited_Financials\" title=\"Sai Parenteral&#8217;s Limited Financials\">Sai Parenteral&#8217;s Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/sai-parenteral-ipo-listing-at-2-04-premium-at-400-00-per-share\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sai_Parenteral_IPO\"><\/span><strong>Sai Parenteral IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>It is a bookbuilding issue IPO of \u20b9408.79 crore, the entire and fresh issue of 0.73 crore shares and an offer for sale of 0.32 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 2nd April 2026. The <strong>Sai Parenteral&#8217;s IPO<\/strong> date is scheduled from 24th March 2026 to 27th March 2026. The face value of Sai Parenteral&#8217;s shares stands at \u20b910 per share, and the IPO Issue price band is set at \u20b9372 to \u20b9392 per share<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>30th April 2026<\/td><\/tr><tr><td><strong>IPO Open Date<\/strong><\/td><td>24th April 2026<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>27th April 2026<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>1st April 2026<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>18,06,000 shares(agg. up to \u20b922 Cr)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,200 Shares<\/td><\/tr><tr><td><strong>Issue Price&nbsp;<\/strong><\/td><td><\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE &amp; SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>2nd April 2026<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sai_Parenteral_Listing\"><\/span><strong>Sai Parenteral Listing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>On the NSE platforms, Sai Parenteral shares are listed at \u20b9400.00 per share, reflecting a 2.04% premium over the issue price of \u20b9392.00 per share, whereas on the BSE, they are listed at \u20b9405.00 per share, reflecting a 3.31% premium.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Sai_Parenteral_Limited\"><\/span><strong>About Sai Parenteral Limited<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Sai Parenteral&#8217;s Ltd. is a diversified pharmaceutical formulations company with expertise in research, development, and manufacturing. The company operates in two segments: Branded Generic Formulations and Contract Development and Manufacturing Organisation (CDMO) products and services for domestic and international markets. The product portfolio spans multiple therapeutic areas, including cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements (VMS), analgesics, and dermatology. Offerings are across dosage forms such as injectables, tablets, capsules, liquid orals, and ointments.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sai_Parenterals_Limited_Financials\"><\/span><strong>Sai Parenteral&#8217;s Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for <strong>Sai Parenteral&#8217;s IPO. <\/strong>See the table for Sai Parenteral&#8217;s Limited&#8217;s financials.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>31st Dec 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><td><strong>31st March 2023<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>376.24<\/td><td>272.39<\/td><td>268.10<\/td><td>133.96<\/td><\/tr><tr><td><strong>Total Income<\/strong><\/td><td>89.43<\/td><td>163.74<\/td><td>155.18<\/td><td>97.03<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>7.76<\/td><td>14.43<\/td><td>8.42<\/td><td>4.38<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>16.24<\/td><td>39.44<\/td><td>31.70<\/td><td>17.64<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>209.37<\/td><td>95.78<\/td><td>76.40<\/td><td>31.49<\/td><\/tr><tr><td><strong>Reserves and Surplus<\/strong><\/td><td>188.84<\/td><td>80.36<\/td><td>61.30<\/td><td>24.34<\/td><\/tr><tr><td><strong>Total Borrowings<\/strong><\/td><td>76.07<\/td><td>93.95<\/td><td>118.79<\/td><td>68.35<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Sai Parenteral&#8217;s Limited&#8217;s revenue increased by 5%, from \u20b910.99 crore in March 2024 to \u20b914.17 crore in March 2025. Moreover, the company&#8217;s PAT increased by 4% from \u20b92.39 crore in March 2024 to \u20b92.52 crore in March 2025.<\/p><p><strong>Recent Articles<\/strong><\/p><p><a href=\"https:\/\/univest.in\/blogs\/emiac-technologies-ipo-gmp-day-1\"><strong>Emiac Technologies IPO GMP: Day 1 IPO Live Updates<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/emiac-technologies-ipo-subscription-status-day-1\"><strong>Emiac Technologies IPO Subscription Status Day 1<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/sai-parenterals-ipo-gmp-day-4\"><strong>Sai Parenteral\u2019s IPO GMP: Day 4 IPO Live Updates<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/powerica-ipo-gmp-day-4\"><strong>Sai Parenteral IPO GMP: Day 4 IPO Live Updates<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/powerica-ipo-subscription-status-day-4\"><strong>Sai Parenteral IPO Subscription Status Day 4&nbsp;<\/strong><\/a><\/p><p><\/p>","protected":false},"excerpt":{"rendered":"<p>Sai Parenteral IPO Listing Today: The Sai Parenteral IPO was subscribed 2.05 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 14.98 times, and non-institutional investors (NIIs) received 1.16 times. The retail quota of the issue was subscribed to 56.03%. Before delving deeper into the topic, go through the<\/p>\n","protected":false},"author":27,"featured_media":66512,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[1015,3847],"class_list":["post-66508","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-ipo","tag-listing-today"],"metadata":{"_edit_lock":["1775111594:27"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["65"],"rank_math_title":["Sai Parenteral IPO Listing Today; Check Share Price in 2026"],"rank_math_description":["Sai Parenteral IPO Listing at \u20b9400.00 at a premium 2.04% against the IPO price of \u20b9392.00 per share. What should be your next move on the Sai Parenteral IPO? Read more to know.\n\n"],"rank_math_focus_keyword":["Sai Parenteral IPO Listing"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["66512"],"_edit_last":["27"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["7349"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/02115536\/Sai-Parenterals-Listing-Today.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/66508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=66508"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/66508\/revisions"}],"predecessor-version":[{"id":66513,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/66508\/revisions\/66513"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/66512"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=66508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=66508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=66508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}